Shaping the future of animal health
Virbac group

Corporate news

Jan 26 - Jean-Pierre Dick, fourth in the Vendée Globe

French skipper Jean-Pierre Dick crossed the finish line of the eighth Vendée Globe at 1347hrs UTC on Wednesday 25th January. The skipper of StMichel Virbac completed his solo round the world voyage in 80 days 1 hour 45 minutes and 45 seconds. Jean-Pierre Dick sailed 27,857 miles at the average speed of 14.5 knots.

Jan 04 - Jesse Mark Chellan appointed general manager of Virbac RSA

Virbac announces the appointment of Jesse Mark Chellan as general manager of Virbac RSA. Based in Johannesburg, he is effective in his role since December 1, 2016. He will be responsible for the development and execution of the long term business strategy for both South Africa and for the export regions of Southern and Sub-Saharan Africa.

Dec 09 - StMichel-Virbac: a brand ambassador

November 6, 2016: Jean-Pierre Dick takes the start of his fourth Vendée Globe. In Les Sables d'Olonne, Sandrine Brunel, Virbac Head of Corporate Communications, talks about the event and discusses the virtuous effects of 15 years of sailing sponsorship.

A company that has always been dedicated to animal health

Founded in 1968 by a French veterinarian, Virbac is an independent pharmaceutical laboratory present in more than 100 countries. The company offers a comprehensive and practical range of products and services covering the majority of species and pathologies.

Join Virbac

Career opportunities, company values, testimonials... Discover our career section.

Customer driven innovation

To meet the customers' essential needs, in almost all the therapeutic segments and for nearly all species. Such is the philosophy of Virbac innovation. For this purpose, the company develops...

Financial public releases

Mar 13 - 2016 annual results

  Strong rebound in profitability in 2016  

Jan 17 - 2016 Annual consolidated sales

  Annual sales growth of 4.5%, at constant exchange rates

Dec 16 - St. Louis: lifting of the Warning Letter for the Virbac production site

Virbac announces that it has received from the Food and drug administration (FDA) a communication confirming the lifting of the Warning Letter received in December 2015 for its St. Louis production site (Missouri, USA).

Corporate responsibility

Company culture, economic and social responsibility, citizenship, environment... From its very beginning, close to fifty years ago, Virbac has taken a long-term view.